// App-Quantinova.ai

3812 : FAK inhibition resensitizes platinum-resistant serous ovarian cancer

Researchers

Presenter

  • Lisa M. Bean

Principal Investigators

  • Florian J. Sulzmaier

  • Isabelle Tancioni

  • Sean Uryu

  • Christine Jean

  • Christine Lawson

  • Xiao Lei Chen

  • Elizabeth G. Kleinschmidt

  • Kristen M. Anderson

  • Edward A. Cordasco

  • Joshua Axelrod

  • Vihren N. Kolev

  • Jonathan A. Pachter

  • Dwayne G. Stupack

  • David D. Schlaepfer

Medical Centers

  • UCSD Moores Cancer Center, La Jolla, CA

  • Verastem, Boston, MA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Gynaecological cancer

  • Mesothelioma

  • Solid malignancies

Biomarkers

  • Focal Adhesion Kinase

Drug/Treatment

  • L-Tyrosine

  • VS4718

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved